Fas ligand  FasL  Apo 1L CD95L  expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1 5 centimeters

Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F

doi:10.1055/s-0029-1241205

Fas ligand FasL Apo 1L CD95L expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1 5 centimeters

Bayraktaroglu T, Boztepe H, Kapran Y, Tanakol R, Alagöl F

article (Uluslararası, Hakemli) | Yazar(lar): Bayraktaroglu T, Boztepe H, Kapran Y, Tanakol R, Alagöl F | Yıl: 2010 | Dergi/Kurum: Experimental and Clinical Endocrinology & Diabetes | İndeks: SCI | DOI: 10.1055/s-0029-1241205 — Zonguldak Bülent Ecevit Üniversitesi (BEUN) ÜBAP Akademik Kaydı.